News

Capridine-Beta is a novel nitroacridine derivative which has shown specific activity against prostate cancer and which, as preclinical toxicology studies have indicated, may be less myelosupressive than commonly

The two companies have initiated enrolment in the international randomized controlled phase III study, named CHOPIN, to evaluate BAL5788 (ceftobiprole) in hospital-acquired pneumonia including ventilator-associated pneumonia. “We are

The study, named EXOTIC-EF, involved intravenous dosing of 400mg of oxypurinol on a one-time basis with measurement of left-ventricle ejection fraction (LVEF) the endpoint. The study was open-label

Wex licensed the European rights to its Tetrodotoxin (TTX) products to Esteve in November 2002 for a commitment of C$62,000,000. This agreement was expanded in March 2005 to

Cigarette smoking promotes lung cancer and many other cancers, heart disease, poor circulation, and emphysema. These are the same diseases, which GenoMed has found to be due to

This study is one of multiple phase II clinical trials that Allergan has sponsored to explore the use of its Botox (botulinum toxin type A) product to treat

XP13512 is a transported prodrug of gabapentin, a drug that has been sold by Pfizer as Neurontin since 1993 and is currently sold as a generic drug by

Gleevec (imatinib mesylate) is a targeted therapeutic with global sales in excess of $1.6 billion in 2004. It was first approved in 2001 for the treatment of advanced-stage

The purchase was made pursuant to an equity transfer agreement entered into by Wyeth and Takeda in May 2003. Takeda’s remaining 30% equity in WKK will be acquired